---
figid: PMC3425519__onc0091211290002
figtitle: Intracellular vascular endothelial growth factor (VEGF) signal transduction
  pathway
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC3425519
filename: onc0091211290002.jpg
figlink: /pmc/articles/PMC3425519/figure/F2/
number: F2
caption: 'Intracellular vascular endothelial growth factor (VEGF) signal transduction
  pathway. Ligands bind to membrane receptors, which are phosphorylated, leading to
  activation of several cytoplasmic messengers, which activate transcription factors
  in the nucleus that involves target genes implicated in the proliferation, angiogenesis,
  apoptosis, and tumor invasion. Shown are some targeted therapies and their main
  inhibition targets [–]. aVEGF A–D ligands bind to VEGF receptors 1–3 with specific
  ligands preferentially binding to a specific receptor (e.g., VEGF A and C ligands
  bind to VEGF receptor 2); bmAb to VEGF A; ctargets VEGF A and B and placental growth
  factor (PlGF); dmAb to VEGF receptor 1; emAb to VEGF receptor 2.Abbreviations: AKT,
  protein kinase B; BCR-ABL, Philadelphia chromosome; BRaf, B-type RAF kinase; C-src,
  cellular sarcoma; Grb, growth factor receptor–bound protein; JAK/STAT, Janus kinases/signal
  transducers and activators of transcription; MAPK, mitogen-activated protein kinase;
  MEK, MAPK kinase; mTOR, mammalian target of rapamycin; PI(4,5)P2, phosphatidylinositol
  (3,4) biphosphate; PI(3,4,5)P3, phosphatidylinositol (3,4,5) triphosphate; PI3K,
  phosphatidylinositol 3-kinase; PTC, papillary thyroid cancer; PTEN, phosphatase
  and tensin homologue; RET, rearranged during transfection; Shc, Src homology 2 domain-containing
  transforming protein; Sos, son of sevenless protein. Adapted from []. Copyright
  2010 Springer. Reprinted with kind permission from Springer Science+Business Media
  B.V.'
papertitle: Targeting Angiogenesis in Metastatic Breast Cancer.
reftext: Sangeetha Reddy, et al. Oncologist. 2012 Aug;17(8):1014-1026.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9497943
figid_alias: PMC3425519__F2
figtype: Figure
redirect_from: /figures/PMC3425519__F2
ndex: fc8bb868-deea-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3425519__onc0091211290002.html
  '@type': Dataset
  description: 'Intracellular vascular endothelial growth factor (VEGF) signal transduction
    pathway. Ligands bind to membrane receptors, which are phosphorylated, leading
    to activation of several cytoplasmic messengers, which activate transcription
    factors in the nucleus that involves target genes implicated in the proliferation,
    angiogenesis, apoptosis, and tumor invasion. Shown are some targeted therapies
    and their main inhibition targets [–]. aVEGF A–D ligands bind to VEGF receptors
    1–3 with specific ligands preferentially binding to a specific receptor (e.g.,
    VEGF A and C ligands bind to VEGF receptor 2); bmAb to VEGF A; ctargets VEGF A
    and B and placental growth factor (PlGF); dmAb to VEGF receptor 1; emAb to VEGF
    receptor 2.Abbreviations: AKT, protein kinase B; BCR-ABL, Philadelphia chromosome;
    BRaf, B-type RAF kinase; C-src, cellular sarcoma; Grb, growth factor receptor–bound
    protein; JAK/STAT, Janus kinases/signal transducers and activators of transcription;
    MAPK, mitogen-activated protein kinase; MEK, MAPK kinase; mTOR, mammalian target
    of rapamycin; PI(4,5)P2, phosphatidylinositol (3,4) biphosphate; PI(3,4,5)P3,
    phosphatidylinositol (3,4,5) triphosphate; PI3K, phosphatidylinositol 3-kinase;
    PTC, papillary thyroid cancer; PTEN, phosphatase and tensin homologue; RET, rearranged
    during transfection; Shc, Src homology 2 domain-containing transforming protein;
    Sos, son of sevenless protein. Adapted from []. Copyright 2010 Springer. Reprinted
    with kind permission from Springer Science+Business Media B.V.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - SRC
  - SERPINA4
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - HRAS
  - NRAS
  - F9
  - TAS2R38
  - PTCH1
  - RET
  - CCDC6
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - BRAF
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - MTOR
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - drk
  - Sos
  - Shc
  - Src64B
  - Pten
  - Akt
  - ras
  - Ras64B
  - Ras85D
  - ptc
  - Ret
  - reticulated
  - reti
  - rets
  - Dsor1
  - Mtk
  - MKP-4
  - p38b
  - rl
  - Stat92E
  - hop
  - bsk
  - Mtor
  - Tor
  - CycE
  - cyc
  - Temsirolimus
  - Vatalanib
  - Vandetanib
  - Dovitinib
  - Cediranib
  - Pazopanib
  - Foretinib
  - Cabozantinib
  - Cancer
  - Lung cancer
  - Noonan syndrome
---
